For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Leo Laboratories Limited

USPTO Granted Patents = 33

% Expired Patents = 81.8

EPO Patents = 10

Trademarks = 1

Forward Citations = 160

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Marc Barry Brown (11 out of 35 patents)

Tahir Nazir (11 out of 12 patents)

Xifu Liang (10 out of 17 patents)

4. Thomas Högberg (6 out of 6 patents)

5. Gunnar Grue-Sørensen (6 out of 9 patents)

6. Steven Martin Ogbourne (5 out of 5 patents)

7. Michael Edward Donald Crothers (4 out of 4 patents)

8. Michael Crothers (4 out of 4 patents)

9. Kristoffer Månsson (4 out of 5 patents)

10. James Harrison Aylward (3 out of 10 patents)

11. Andreas Suhrbier (3 out of 9 patents)

12. Per Vedsø (3 out of 3 patents)

13. Thomas Hogberg (3 out of 4 patents)

14. Gunnar Grue-Sorensen (3 out of 3 patents)

15. Anne Marie Horneman (3 out of 9 patents)

Core Competencies:

Ingenol Mebutate

Therapeutic Compositions

Skin Lesions

Actinic Keratosis

Seborrheic Keratosis

Ingenol-3-Angelate

Virally Induced Lesions

Solid Cancers

Crystalline Ingenol

Topical Treatment

3-O-Acyl-Ingenol

Ingenol-3-Acylates

33 patents: Sort by Forward Citations

1. 10143638 - Method of treating skin with ingenol mebutate (2018-12-04),

2. 9895334 - Treatment of virally induced lesions (2018-02-20),

3. 9861603 - Therapeutic compositions (2018-01-09),

4. 9833429 - Therapeutic compositions (2017-12-05),

5. 9833428 - Therapeutic compositions (2017-12-05),

6. 9820959 - Therapeutic compositions (2017-11-21),

7. 9789078 - Method of topically treating actinic keratosis with ingenol mebutate cycle therapy (2017-10-17),

8. 9713608 - Method for topically treating actinic keratosis on the trunk (except chest) or extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate) (2017-07-25),

9. 9708286 - Ingenol-3-acylates III and ingenol-3-carbamates (2017-07-18),

10. 9676698 - Method of producing ingenol-3-angelate (2017-06-13),

11. 9656945 - 3-acyl-ingenols II (2017-05-23),

12. 9624157 - Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol (2017-04-18),

13. 9603822 - Therapeutic compositions (2017-03-28),

14. 9526714 - Method for treating skin lesions with ingenol mebutate (2016-12-27),

15. 9440906 - Crystalline ingenol mebutate (2016-09-13),

Company Overview

Leo Laboratories Limited, based in Dublin, specializes in the development and manufacturing of innovative healthcare solutions. The company focuses on advanced formulations and delivery systems, catering to various therapeutic areas. With a commitment to research and development, Leo Laboratories aims to enhance patient outcomes through cutting-edge technology and high-quality products. Its expertise spans pharmaceuticals and medical devices, positioning the company as a key player in the healthcare sector within Europe and beyond.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

33 Patents

#51 in Dublin

#84 in Ireland

#20,162 in the World

Dublin, Ireland

Leo Laboratories Limited

Forward Citations = 160

39 inventors:

Marc Barry Brown (11 out of 35 patents)

Tahir Nazir (11 out of 12 patents)

Xifu Liang (10 out of 17 patents)

4. Thomas Högberg (6 out of 6 patents)

5. Gunnar Grue-Sørensen (6 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Leo Laboratories Limited. Retrieved from https://idiyas.com/company/leo-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…